BackgroundCheck.run
Search For

Paul Charles Zamora, 57859 SE Shadowood Dr, Bend, OR 97702

Paul Zamora Phones & Addresses

Bend, OR   

7241 Imbach Pl, Moorpark, CA 93021   

2000 Eastridge Ct, Albuquerque, NM 87112    505-2943737   

422 Imperial Dr, Pacifica, CA 94044   

Newbury Park, CA   

San Mateo, CA   

Ventura, CA   

Mentions for Paul Charles Zamora

Paul Zamora resumes & CV records

Resumes

Paul Zamora Photo 35

Learning User Experience Consulting Specialist

Location:
Bend, OR
Industry:
Accounting
Work:
Amgen since Mar 2009
Sr./Lead Training Developer — eLearning Services
Amgen, Inc. Sep 2006 - Mar 2009
Mgr Research Operations/eDesigner
Parsons Corporation Jan 2003 - Sep 2006
Sr. Training Manager
Genentech, Inc. Apr 2001 - Dec 2003
Multimedia Specialist
Quokka Sports 1999 - Apr 2001
Media Services Manager
LIN Media / KRQE-TV Channel 13 1989 - 1997
Master Control Op / Production Tech
Education:
The University of New Mexico 1986 - 1991
Bachelors, Bachelor of Arts, Communications
Skills:
Elearning Development, Multimedia, Broadcast Production, Broadcast Operations, Online Video, Graphic Design, Audio Post Production, Trivantis Lectora, Streaming Media, Graphic Design, Video Production, Content Development, Lectora, Content Management, Video, Powerpoint, Photoshop, Social Media, Blended Learning, Web Design, Production, Captivate, Customer Service, Illustrator, E Learning, Web Video, Video Editing, Instructional Design, Learning Management Systems, Dreamweaver, Adobe Creative Suite, Training, Editing, Addie, Learning Management
Interests:
Social Services
Health
Certifications:
Fka Training Certificate - Instructional Design
Elearning Design
Friesen, Kaye and Associates
William Horton Consulting
Paul Zamora Photo 36

Paul Zamora

Paul Zamora Photo 37

Paul Zamora

Paul Zamora Photo 38

Paul Zamora

Publications & IP owners

Us Patents

Absorbable Brachytherapy And Chemotherapy Delivery Devices And Methods

US Patent:
2002005, May 9, 2002
Filed:
Apr 27, 2001
Appl. No.:
09/845035
Inventors:
William Mavity - Los Altos CA, US
Robert Stern - Mountain View CA, US
Shigemasa Osaki - Sandy UT, US
Paul Zamora - Gaithersburg MD, US
International Classification:
A61N005/00
US Classification:
600/003000
Abstract:
Combination radiation delivery and chemotherapy devices comprise bioabsorbable structures with radionuclides and chemotherapeutic agents immobilized on said structures. The bioabsorbable structures have a predefined persistence period which is usually substantially greater than the half-life of the radionuclides, thus assuring that the radionuclides remain localized and sequestered at a desired target site while significant radioactivity remains. The radiation delivery and chemotherapy devices are suitable for a wide variety of medical purposes, being particularly suitable for the treatment of solid tumors by injection or open surgical introduction of the devices at a target site. Kits comprising the devices together with instructions for use are also provided.

Direct Labeling Of Peptides With Metal Ions

US Patent:
5861139, Jan 19, 1999
Filed:
Jun 5, 1995
Appl. No.:
8/464529
Inventors:
Buck A. Rhodes - Albuquerque NM
Paul O. Zamora - Albuquerque NM
International Classification:
A61K 5100
A61M 3614
US Classification:
424 169
Abstract:
Proteins containing one or more disulfide bonds or monosulfides are labeled with medically useful metal ions for use in diagnosis and treatment of a variety of pathologic conditions. Labeling is accomplished with a variety of metals, including radiometals, by using a reducing agent to reduce the disulfide bonds to thiolate groups; excess reducing agent, reaction by-products and any impurities are removed; and, a source of Sn (II) agent is added to the thiolate-containing protein. The resulting product may be stored frozen or lyophilized, with labeling accomplished by the addition of the medically useful metal ions.

Direct Labeling Of Antibodies And Other Protein With Metal Ions

US Patent:
5460785, Oct 24, 1995
Filed:
Jan 3, 1992
Appl. No.:
7/816477
Inventors:
Buck A. Rhodes - Albuquerque NM
Paul O. Zamora - Albuquerque NM
Assignee:
RhoMed Incorporated - Albuquerque NM
International Classification:
A61K 4902
A61K 4300
A61K 39395
C07B 5900
US Classification:
424 149
Abstract:
Proteins containing one or more dtsulfide bonds or monosulfides are labeled with medically useful metal ions for use in diagnosis and treatment of a variety of pathologtc conditions. Labeling is accomplished with a variety of metals, including radiometals, by using a reducing agent to reduce the disulfide bonds to thiolate groups; excess reducing agent, reaction by-products and any impurities are removed; and, a source of Sn (II) agent is added to the thiolate-containing protein. The resulting product may be stored frozen or lyophilized, with labeling accomplished by the addition of the medically useful metal ions.

Peptide-Metal Ion Pharmaceutical Labeling Method

US Patent:
5690905, Nov 25, 1997
Filed:
May 31, 1995
Appl. No.:
8/454950
Inventors:
Paul O. Zamora - Albuquerque NM
Buck A. Rhodes - Albuquerque NM
Assignee:
Rhomed Incorporated - Albuquerque NM
International Classification:
A61K 5100
A61M 3614
US Classification:
424 169
Abstract:
Peptides containing a biological-function domain and a medically useful metal ion-binding domain are labeled with medically useful metal ions for use in diagnosis and treatment of a variety of pathologic conditions. The peptides have the amino acid sequence (R. sub. 1)--�Y. sub. 1 !. sub. n --(R. sub. 2), (R. sub. 1)--�Y. sub. 1 --(R. sub. 2)--Y. sub. 1 !. sub. n --(R. sub. 3) and (R. sub. 1)--�Y. sub. 1 --(R. sub. 2)--Y. sub. 2 !. sub. n --(R. sub. 3) wherein the medically useful metal ion-binding domain is �Y. sub. 1 !. sub. n, �Y. sub. 1 --(R. sub. 2)--Y. sub. 1 !. sub. n or �Y. sub. 1 --(R. sub. 2)--Y. sub. 2 !. sub. n, in which n is a number between 1 and about 6 and Y. sub. 1 and Y. sub. 2 are amino acids with a sulfur, nitrogen or oxygen which is available for binding to metal ions, or can be made available for binding to metal ions; the biological-function domain is an amino acid sequence containing from 1 to about 20 amino acids located in any one or more of R. sub. 1, R. sub. 2 or R. sub. 3 ; and those portions of R. sub. 1, R. sub. 2 and R. sub.

Absorbable Brachytherapy And Chemotherapy Delivery Devices And Methods

US Patent:
6248057, Jun 19, 2001
Filed:
Jul 27, 1999
Appl. No.:
9/361553
Inventors:
William G. Mavity - Los Altos CA
Robert A. Stern - Mountain View CA
Shigemasa Osaki - Sandy UT
Paul O. Zamora - Gaithersburg MD
Assignee:
Innerdyne, Inc. - Sunnyvale CA
International Classification:
A61N 500
US Classification:
600 3
Abstract:
Combination radiation delivery and chemotherapy devices comprise bioabsorbable structures with radionuclides and chemotherapeutic agents immobilized on said structures. The bioabsorbable structures have a predefined persistence period which is usually substantially greater than the half-life of the radionuclides, thus assuring that the radionuclides remain localized and sequestered at a desired target site while significant radioactivity remains. The radiation delivery and chemotherapy devices are suitable for a wide variety of medical purposes, being particularly suitable for the treatment of solid tumors by injection or open surgical introduction of the devices at a target site. Kits comprising the devices together with instructions for use are also provided.

Peptides Method For Radiolabeling Them, And Method For Detecting Inflammation

US Patent:
5670133, Sep 23, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/484184
Inventors:
Paul O. Zamora - Albuquerque NM
Assignee:
Rhomed Incorporated - Albuquerque NM
International Classification:
A61K 4900
G01N 3100
G01N 3348
US Classification:
424 91
Abstract:
High affinity chemotactic peptides containing a biological-function domain and a medically useful metal ion-binding domain are labeled with medically useful metal ions for use in diagnosis and treatment of infections, inflammations and related conditions.

Peptide-Metal Ion Pharmaceutical Preparation And Method

US Patent:
5443816, Aug 22, 1995
Filed:
Feb 20, 1992
Appl. No.:
7/840077
Inventors:
Paul O. Zamora - Albuquerque NM
Buck A. Rhodes - Albuquerque NM
Assignee:
Rhomed Incorporated - Albuquerque NM
International Classification:
A61K 4900
A61K 5108
US Classification:
424 169
Abstract:
Peptides containing a biological-function domain and a medically useful metal ion-binding domain are labeled with medically useful metal ions for use in diagnosis and treatment of a variety of pathologic conditions. The peptides have the amino acid sequence (R. sub. 1)-[Y. sub. 1 ]. sub. n -(R. sub. 2), (R. sub. 1)-[Y. sub. 1 -(R. sub. 2)-Y. sub. 1 ]. sub. n -(R. sub. 3) and (R. sub. 1)-[Y. sub. 1 -(R. sub. 2)-Y. sub. 2 ]. sub. n -(R. sub. 3) wherein the medically useful metal ion-binding domain is [Y. sub. 1 ]. sub. n, [Y. sub. 1 -(R. sub. 2)-Y. sub. 1 ]. sub. n or [Y. sub. 1 -(R. sub. 2)-Y. sub. 2 ]. sub. n in which n is a number between 1 and about 6 and Y. sub. 1 and Y. sub. 2 are amino acids with a sulfur, nitrogen or oxygen which is available for binding to metal ions, or can be made available for binding to metal ions; the biological-function domain is an amino acid sequence containing from 1 to about 20 amino acids located in any one or more of R. sub. 1, R. sub. 2 or R. sub. 3 ; and those portions of R. sub. 1, R. sub. 2 and R. sub.

Yigsr Peptide Radiopharmaceutical Applications

US Patent:
5556609, Sep 17, 1996
Filed:
Dec 30, 1992
Appl. No.:
7/998910
Inventors:
Paul O. Zamora - Albuquerque NM
Assignee:
RhoMed Incorporated - Albuquerque NM
International Classification:
A61K 5100
C07K 200
C07F 500
US Classification:
424 169
Abstract:
Peptides containing a biological-function domain which includes the sequence Tyr-Ile-Gly-Ser-Arg (YIGSR) SEQ. ID No. 1) and a medically useful metal ion-binding domain are labeled with medically useful metal ions for use in a variety of diseases and pathologic conditions, and particularly for diagnosis and treatment of thrombosis and other diseases and conditions.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.